Judah Weinberger is a Cardiology physician affiliated with Touro College. OpenAlex indexes 35 publications with 2,108 citations (h-index 20).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingMedicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
92.8%Statin25.3%Rosuvastatin Calcium52%Atorvastatin Calcium48%Part D≥24 patientsBeta blocker18.3%Metoprolol Succinate75%Carvedilol14%Metoprolol Tartrate11%Part D<11 patients+ 7 more classes in this area
Blood & clotting
4.5%Factor Xa inhibitor4.5%Eliquis100%Part D<11 patientsMetabolism & gastrointestinal
2.6%SGLT2 inhibitor2.6%Jardiance100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1987–1993 per NIH RePORTER. The latest:
- CELLULAR METABOLISM IN RESPONSE TO HYPERCHOLESTEROLEMIA
Columbia Univ New York Morningside
FY1993R01HL042392 - CELLULAR METABOLISM IN RESPONSE TO HYPERCHOLESTEROLEMIA
Columbia Univ New York Morningside
FY1992R01HL042392 - CELLULAR METABOLISM IN RESPONSE TO HYPERCHOLESTEROLEMIA
Columbia Univ New York Morningside
FY1991R01HL042392
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Evaluation of drug‐eluting stents' coating durability—Clinical and regulatory implications
Journal of Biomedical Materials Research Part B Applied Biomaterials
2009 - Drug‐eluting stent with improved durability and controllability properties, obtained via electrocoated adhesive promotion layer
Journal of Biomedical Materials Research Part B Applied Biomaterials
2009
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”